Skip to main content
. 2016 Dec 16;8(5):7878–7890. doi: 10.18632/oncotarget.13987

Figure 2. Antiproliferative and apoptotic activities of BEZ235, BKM120 and everolimus (EVE) in LMS cell lines.

Figure 2

Growth curves indicating growth inhibition of the 3 LMS cell lines (IB112, 134 and 136) after treatment for 72 hours (A). Representative pictures of the clone formation assay for cell lines treated for 72 hours by PI3K/mTOR pathway inhibitors at their IC50 value (B). The average percentage of monoclonal cell number for each cell line (C).